Terms: = Brain cancer AND CTNNB1, P35222, 1499, ENSG00000168036, CTNNB
172 results:
1. Identification of core genes of craniopharyngioma angiogenesis based on single-cell nuclear transcriptome sequencing.
Zhang J; Xu L; Ye J; Xu C; Wu B; Wu J; Hong T
Cell Mol Biol (Noisy-le-grand); 2024 Mar; 70(3):136-141. PubMed ID: 38650143
[TBL] [Abstract] [Full Text] [Related]
2. Investigation of iso-propylchaetominine anticancer activity on apoptosis, cell cycle and Wnt signaling pathway in different cancer models.
Karamad V; Sogutlu F; Ozkaya FC; Shademan B; Ebrahim W; El-Neketi M; Avci CB
Fitoterapia; 2024 Mar; 173():105789. PubMed ID: 38158162
[TBL] [Abstract] [Full Text] [Related]
3. Miliary brain metastases from lung adenocarcinoma with EGFR (L858R) and ctnnb1 mutations.
Kunishige M; Takeuchi E
Thorac Cancer; 2023 Dec; 14(34):3419-3420. PubMed ID: 37920971
[TBL] [Abstract] [Full Text] [Related]
4. Over-representation analysis of angiogenic factors in immunosuppressive mechanisms in neoplasms and neurological conditions during COVID-19.
Chatterjee S; Sanjeev BS
Microb Pathog; 2023 Dec; 185():106386. PubMed ID: 37865274
[TBL] [Abstract] [Full Text] [Related]
5. [Craniopharyngiomas: The Dawn of a New Era with the Elucidation of Driver Genes].
Fujio S; Hanaya R
No Shinkei Geka; 2023 Sep; 51(5):917-928. PubMed ID: 37743344
[TBL] [Abstract] [Full Text] [Related]
6. [Histological Classification and Diagnosis of Sellar/Parasellar Tumors].
Nishioka H
No Shinkei Geka; 2023 Sep; 51(5):789-798. PubMed ID: 37743330
[TBL] [Abstract] [Full Text] [Related]
7. Genomic alterations associated with rapid progression of brain metastases.
Uggerly ASV; Cummins DD; Nguyen MP; Saggi S; Goldschmidt E; Chang EF; McDermott MW; Berger MS; Theodosopoulos PV; Hervey-Jumper SL; Daras M; Aghi MK; Morshed RA
Neurosurg Focus; 2023 Aug; 55(2):E15. PubMed ID: 37527682
[TBL] [Abstract] [Full Text] [Related]
8. First report of medulloblastoma in a patient with MUTYH-associated polyposis.
Villy MC; Warcoin M; Filser M; Buecher B; Golmard L; Suybeng V; Schwartz M; Bieche I; Vacher S; Laurence V; Bourdeaut F; Bernier M; Gutman T; Stoppa-Lyonnet D; Masliah-Planchon J; Colas C
Neuropathol Appl Neurobiol; 2023 Aug; 49(4):e12929. PubMed ID: 37524406
[TBL] [Abstract] [Full Text] [Related]
9. [Etiology, Genetic Features and Clinical Presentations in Craniopharyngiomas].
Horiguchi K
No Shinkei Geka; 2023 Jul; 51(4):607-614. PubMed ID: 37491057
[TBL] [Abstract] [Full Text] [Related]
10. Craniopharyngioma in Pediatrics and Adults.
Piloni M; Gagliardi F; Bailo M; Losa M; Boari N; Spina A; Mortini P
Adv Exp Med Biol; 2023; 1405():299-329. PubMed ID: 37452943
[TBL] [Abstract] [Full Text] [Related]
11. Craniopharyngioma-An update on metabolic and cognitive complications and new therapy.
Erfurth EM
J Intern Med; 2023 Sep; 294(3):269-280. PubMed ID: 37424210
[TBL] [Abstract] [Full Text] [Related]
12. Exosomal circ-AHCY promotes glioblastoma cell growth via Wnt/β-catenin signaling pathway.
Li Y; Zheng X; Wang J; Sun M; Li D; Wang Z; Li J; Li Y; Liu Y
Ann Clin Transl Neurol; 2023 Jun; 10(6):865-878. PubMed ID: 37150844
[TBL] [Abstract] [Full Text] [Related]
13. Endometrioid Adenocarcinoma Resembling Cutaneous Pilomatrix Carcinoma: A Case Report of an Aggressive Neoplasm in a Young Woman With Diffusely Aberrant Beta-catenin Expression and Associated Morular Metaplasia and Atypical Polypoid Adenomyoma-type Change.
Keane E; Floyd R; McDonnell C; Beirne JP; Ó'Riain C; Komanyane L
Int J Gynecol Pathol; 2023 Sep; 42(5):466-471. PubMed ID: 36811845
[TBL] [Abstract] [Full Text] [Related]
14. Molecular biological features of cyst wall of adamantinomatous craniopharyngioma.
Zhao C; Wang Y; Liu H; Qi X; Zhou Z; Wang X; Lin Z
Sci Rep; 2023 Feb; 13(1):3049. PubMed ID: 36810626
[TBL] [Abstract] [Full Text] [Related]
15. The molecular pathogenesis of craniopharyngiomas.
Campanini ML; Almeida JP; Martins CS; de Castro M
Arch Endocrinol Metab; 2023 Mar; 67(2):266-275. PubMed ID: 36748936
[TBL] [Abstract] [Full Text] [Related]
16. Contemporary Biological Insights and Clinical Management of Craniopharyngioma.
Apps JR; Muller HL; Hankinson TC; Yock TI; Martinez-Barbera JP
Endocr Rev; 2023 May; 44(3):518-538. PubMed ID: 36574377
[TBL] [Abstract] [Full Text] [Related]
17. PBRM1 and BAP1: novel genetic mutations in malignant transformation of craniopharyngioma-a case report.
Tamura M; Yokogami K; Watanabe T; Kawano T; Muta J; Yamashita S; Oguri N; Sato Y; Takeshima H
Brain Tumor Pathol; 2023 Jan; 40(1):40-44. PubMed ID: 36369599
[TBL] [Abstract] [Full Text] [Related]
18. Genetic alterations of TP53 and OTX2 indicate increased risk of relapse in WNT medulloblastomas.
Goschzik T; Mynarek M; Doerner E; Schenk A; Spier I; Warmuth-Metz M; Bison B; Obrecht D; Struve N; Kortmann RD; Schmid M; Aretz S; Rutkowski S; Pietsch T
Acta Neuropathol; 2022 Dec; 144(6):1143-1156. PubMed ID: 36181537
[TBL] [Abstract] [Full Text] [Related]
19. Single-cell DNA sequencing identifies risk-associated clonal complexity and evolutionary trajectories in childhood medulloblastoma development.
Danilenko M; Zaka M; Keeling C; Crosier S; Lyman S; Finetti M; Williamson D; Hussain R; Coxhead J; Zhou P; Hill RM; Hicks D; Rand V; Joshi A; Schwalbe EC; Bailey S; Clifford SC
Acta Neuropathol; 2022 Sep; 144(3):565-578. PubMed ID: 35831448
[TBL] [Abstract] [Full Text] [Related]
20. A systematic review of molecular alterations in invasive non-functioning pituitary adenoma.
Hosseinkhan N; Honardoost M; Emami Z; Cheraghi S; Hashemi-Madani N; Khamseh ME
Endocrine; 2022 Sep; 77(3):500-509. PubMed ID: 35711030
[TBL] [Abstract] [Full Text] [Related]
[Next]
